BIO-RAD LABORATORIES, INC. — Director's Dealing 2020

Sep 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-09-04

Reporting Person: HUTTON RONALD W (Vice President and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-04	Bio-Rad A Common Stock	M	180	—	Acquired	4425.2875	Direct
2020-09-04	Bio-Rad A Common Stock	F	63	$484.23	Disposed	4362.2875	Direct
2020-09-05	Bio-Rad A Common Stock	M	180	—	Acquired	4542.2875	Direct
2020-09-05	Bio-Rad A Common Stock	F	63	$484.23	Disposed	4479.2875	Direct
2020-09-07	Bio-Rad A Common Stock	M	170	—	Acquired	4649.2875	Direct
2020-09-07	Bio-Rad A Common Stock	F	59	$484.23	Disposed	4590.2875	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-04	Restricted Stock Units	$0	M	180	Disposed		Bio-Rad A Common Stock (180)	Direct
2020-09-05	Restricted Stock Units	$0	M	180	Disposed		Bio-Rad A Common Stock (180)	Direct
2020-09-07	Restricted Stock Units	$0	M	170	Disposed		Bio-Rad A Common Stock (170)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 4, 2019.

F4: The restricted stock units vest in five equal annual installments beginning September 5, 2018.

F5: The restricted stock units vest in five equal annual installments beginning September 7, 2017.